Aquestive Therapeutics Inc
AQST
Get informed when a big investor buys or sells
+ FollowMarket Cap$463.6M
Close$
$-1.83
149% downside
Current Fair Value
149% downsideOvervalued by 149% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $463.60 Million |
|---|---|
| Enterprise Value | $401.70 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.76 |
| Beta | 1.45 |
| Outstanding Shares | 122,609,995 |
Return
| Return on Equity | 202.36% |
|---|---|
| Return on Assets | -48.83% |
| Return on Invested Capital | -52.03% |
Valuation & Multiples
| P/E Ratio | -6.06 |
|---|---|
| PEG | 9.34 |
| Price to Sales | - |
| Price to Book Ratio | -3.74 |
| Enterprise Value to Revenue | 7.99 |
| Enterprise Value to EBIT | -7.06 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | -1.43 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$10.90 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$11.42 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 34.52% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.58%▼ 56.05% |
|---|---|
| Total Invested | $13.17M▼ 95.78% |
| Investors Holding | 34▼ 152.00% |
ESG Score
No data